243 related articles for article (PubMed ID: 33548978)
1. MiRNA -483-5p as a Potential Noninvasive Biomarker for Early Detection of Alzheimer's Disease.
Sabry R; El Sharkawy RE; Gad NM
Egypt J Immunol; 2020 Jun; 27(2):59-72. PubMed ID: 33548978
[TBL] [Abstract][Full Text] [Related]
2. Beyond CSF and Neuroimaging Assessment: Evaluating Plasma miR-145-5p as a Potential Biomarker for Mild Cognitive Impairment and Alzheimer's Disease.
Wen Q; Wittens MMJ; Engelborghs S; van Herwijnen MHM; Tsamou M; Roggen E; Smeets B; Krauskopf J; Briedé JJ
ACS Chem Neurosci; 2024 Mar; 15(5):1042-1054. PubMed ID: 38407050
[TBL] [Abstract][Full Text] [Related]
3. A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.
Guo R; Fan G; Zhang J; Wu C; Du Y; Ye H; Li Z; Wang L; Zhang Z; Zhang L; Zhao Y; Lu Z
J Alzheimers Dis; 2017; 60(4):1365-1377. PubMed ID: 29036818
[TBL] [Abstract][Full Text] [Related]
4. Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer's disease.
Siedlecki-Wullich D; Català-Solsona J; Fábregas C; Hernández I; Clarimon J; Lleó A; Boada M; Saura CA; Rodríguez-Álvarez J; Miñano-Molina AJ
Alzheimers Res Ther; 2019 May; 11(1):46. PubMed ID: 31092279
[TBL] [Abstract][Full Text] [Related]
5. Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.
Cosín-Tomás M; Antonell A; Lladó A; Alcolea D; Fortea J; Ezquerra M; Lleó A; Martí MJ; Pallàs M; Sanchez-Valle R; Molinuevo JL; Sanfeliu C; Kaliman P
Mol Neurobiol; 2017 Sep; 54(7):5550-5562. PubMed ID: 27631879
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA Expression Signature in Mild Cognitive Impairment Due to Alzheimer's Disease.
De Felice B; Montanino C; Oliva M; Bonavita S; Di Onofrio V; Coppola C
Mol Neurobiol; 2020 Nov; 57(11):4408-4416. PubMed ID: 32737762
[TBL] [Abstract][Full Text] [Related]
7. Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer's disease patients from non-demented subjects.
Nagaraj S; Laskowska-Kaszub K; Dębski KJ; Wojsiat J; Dąbrowski M; Gabryelewicz T; Kuźnicki J; Wojda U
Oncotarget; 2017 Mar; 8(10):16122-16143. PubMed ID: 28179587
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of endogenous control miRNAs in plasma samples for normalization of qPCR data for Alzheimer's disease.
Dakterzada F; Targa A; Benítez ID; Romero-ElKhayat L; de Gonzalo-Calvo D; Torres G; Moncusí-Moix A; Huerto R; Sánchez-de-la-Torre M; Barbé F; Piñol-Ripoll G
Alzheimers Res Ther; 2020 Dec; 12(1):163. PubMed ID: 33278902
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer's disease.
Kumar S; Vijayan M; Reddy PH
Hum Mol Genet; 2017 Oct; 26(19):3808-3822. PubMed ID: 28934394
[TBL] [Abstract][Full Text] [Related]
10. Can Peripheral MicroRNA Expression Data Serve as Epigenomic (Upstream) Biomarkers of Alzheimer's Disease?
Yılmaz ŞG; Erdal ME; Özge AA; Sungur MA
OMICS; 2016 Aug; 20(8):456-61. PubMed ID: 27501295
[TBL] [Abstract][Full Text] [Related]
11. The plasma derived exosomal miRNA-483-5p/502-5p serve as potential MCI biomarkers in aging.
Liu T; Li N; Pu J; Zhang C; Xu K; Wang W; Liu L; Gao L; Xu X; Tan J
Exp Gerontol; 2024 Feb; 186():112355. PubMed ID: 38190948
[TBL] [Abstract][Full Text] [Related]
12. Plasma d-glutamate levels for detecting mild cognitive impairment and Alzheimer's disease: Machine learning approaches.
Chang CH; Lin CH; Liu CY; Huang CS; Chen SJ; Lin WC; Yang HT; Lane HY
J Psychopharmacol; 2021 Mar; 35(3):265-272. PubMed ID: 33586518
[TBL] [Abstract][Full Text] [Related]
13. Accuracy and Psychometric Properties of the Brazilian Version of the Montreal Cognitive Assessment as a Brief Screening Tool for Mild Cognitive Impairment and Alzheimer's Disease in the Initial Stages in the Elderly.
Pinto TCC; Machado L; Costa MLG; Santos MSP; Bulgacov TM; Rolim APP; Silva GA; Rodrigues-Júnior AL; Sougey EB; Ximenes RCC
Dement Geriatr Cogn Disord; 2019; 47(4-6):366-374. PubMed ID: 31466064
[TBL] [Abstract][Full Text] [Related]
14. Circulating MicroRNAs as Diagnostic Biomarkers of Clinical Cognitive Impairment: A Meta-Analysis.
Shi D; Han M; Liu W; Tao J; Chen L
Am J Alzheimers Dis Other Demen; 2020; 35():1533317520951686. PubMed ID: 33094634
[TBL] [Abstract][Full Text] [Related]
15. An investigation of microRNA-103 and microRNA-107 as potential blood-based biomarkers for disease risk and progression of Alzheimer's disease.
Wang J; Chen C; Zhang Y
J Clin Lab Anal; 2020 Jan; 34(1):e23006. PubMed ID: 31420923
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
[TBL] [Abstract][Full Text] [Related]
17. A subtest analysis of the Montreal cognitive assessment (MoCA): which subtests can best discriminate between healthy controls, mild cognitive impairment and Alzheimer's disease?
Cecato JF; Martinelli JE; Izbicki R; Yassuda MS; Aprahamian I
Int Psychogeriatr; 2016 May; 28(5):825-32. PubMed ID: 26620850
[TBL] [Abstract][Full Text] [Related]
18. Is the Montreal Cognitive Assessment (MoCA) screening superior to the Mini-Mental State Examination (MMSE) in the detection of mild cognitive impairment (MCI) and Alzheimer's Disease (AD) in the elderly?
Pinto TCC; Machado L; Bulgacov TM; Rodrigues-Júnior AL; Costa MLG; Ximenes RCC; Sougey EB
Int Psychogeriatr; 2019 Apr; 31(4):491-504. PubMed ID: 30426911
[TBL] [Abstract][Full Text] [Related]
19. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]